Lixin Qiao

USPTO Granted Patents = 40 (Patent Applications = 10)

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 6.2

ph-index = 13

Forward Citations = 711(Granted Patents)

Location History:

Tewksbury, MA (US) (2012 - 2021)
Andover, MA (US) (2012 - 2023)

Company Filing History:

18 out of 44

Celgene Avilomics Research, Inc.

The Brigham and Women's Hospital, Inc.

patents

4. 5 out of 263

Massachusetts Eye and Ear Infirmary

patents

5. 2 out of 5

Avila Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

Areas of Expertise:

Ligand-Directed Covalent Modification

Protein Kinase Inhibitors

Atoh1 Expression Enhancement

MK2 Inhibitors

2,4-Disubstituted Pyrimidines

ERK Inhibitors

HCV Protease Inhibitors

Bifunctional Synthetic Molecules

Substituted Diaminopyrimidines

Eph B-3 Kinase Inhibition

Kinase Conjugates

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542492 - Ligand-directed covalent modification of protein (2023-01-03),

2. 11351168 - 2,4-disubstituted pyrimidines useful as kinase inhibitors (2022-06-07),

3. 11160808 - Compounds that enhance Atoh1 expression (2021-11-02),

4. 11098061 - MK2 inhibitors and uses thereof (2021-08-24),

5. 10828300 - Substituted 2,4-diaminopyrimidines as kinase inhibitors (2020-11-10),

6. 10662195 - Protein kinase conjugates and inhibitors (2020-05-26),

7. 10596172 - 2,4-disubstituted pyrimidines useful as kinase inhibitors (2020-03-24),

8. 10406163 - Compounds that enhance Atoh1 expression (2019-09-10),

9. 10138256 - MK2 inhibitors and uses thereof (2018-11-27),

10. 10010548 - 2,4-disubstituted pyrimidines useful as kinase inhibitors (2018-07-03),

11. 9987276 - Substituted 2,4-diaminopyrimidines as kinase inhibitors (2018-06-05),

12. 9980964 - ERK inhibitors and uses thereof (2018-05-29),

13. 9796700 - ERK inhibitors and uses thereof (2017-10-24),

14. 9694086 - HCV protease inhibitors and uses thereof (2017-07-04),

15. 9676785 - HCV protease inhibitors and uses thereof (2017-06-13),

Title: The Innovative Journey of Inventor Lixin Qiao

Introduction: Lixin Qiao is a pioneering inventor based in Tewksbury, MA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Lixin Qiao holds several patents in the areas of telecommunications, networking, and software development, showcasing his expertise and creativity in these domains.

Career Highlights: With a career spanning over two decades, Lixin Qiao has worked with leading tech companies, where he has spearheaded research and development projects that have resulted in cutting-edge inventions and solutions.

Collaborations: Throughout his career, Lixin Qiao has collaborated with top researchers, engineers, and developers, both within the United States and internationally, to bring his innovative ideas to life and make a lasting impact on the industry.

Conclusion: Lixin Qiao's passion for innovation, coupled with his technical acumen and collaborative spirit, continues to drive his success as an inventor, inspiring the next generation of innovators to push the boundaries of what is possible in the world of technology.

This text is generated by artificial intelligence and may not be accurate.